Company / SG&A per Share
Arcadia Biosciences, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$7.06
FY2025
5-year range
$1.22 / $41.36
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share returned to growth in FY2025 after 2 years of decline, reaching $7.06.
Based on SEC 10-K filings.
7.06 in FY2025 with a 5-year CAGR of +35.1%.
Improved from $24.41 to $7.06 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -44.5%
- 5-Year CAGR
- +35.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 10.3% year-over-year.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.06 | +10.3% |
| FY2024 | $6.41 | -73.8% |
| FY2023 | $24.41 | -41.0% |
| FY2022 | $41.36 | +3278.3% |
| FY2021 | $1.22 | -22.0% |
| FY2020 | $1.57 | -35.4% |
| FY2019 | $2.43 | -51.3% |
| FY2018 | $4.99 | -9.4% |
| FY2017 | $5.51 | +2088.4% |
| FY2016 | $0.25 | -94.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026